4 Biotech Firms Freshen Pipeline With IPOs Totaling $526M
Four biotechnology companies set price ranges Monday on initial public offerings that could raise a combined $526 million to develop drugs that fight cancer and other diseases, signaling a busy start...To view the full article, register now.
Already a subscriber? Click here to view full article